Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

The results suggest that CGM provides an additive benefit to semaglutide, leading to greater decreases in HbA1c. Expanded use of these complementary therapies in the primary care setting could enable more people with T2D to achieve their glycemic goals.

Authors

Poorva Nemlekar (ORCID: https://orcid.org/0009-0003-7092-5295)

Publication Details

Journal: The American Journal of Managed Care
Published: 2025-04-01
DOI: https://doi.org/10.37765/ajmc.2025.89719
Citations: 1
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 1.29

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Poorva Nemlekar

Apr 1, 2025

1 citations

The American Journal of Managed Care

Diabetes Treatment and Management

1.29

article

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Poorva Nemlekar

April 1, 2025article en

1 citations

Abstract

The American Journal of Managed CareVol. 31(4)

Openalex Percentile: Top 21%

Diabetes Treatment and Management

1.29

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims — Poorva Nemlekar · The American Journal of Managed Care (2025) | TGRS Research Map | TGRS